Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Endocrine 1CNS 1

Conditions

Pheochromocytoma 1Paraganglioma 1Neuroendocrine Tumors 1Neuroblastoma 1

Interventions

gallium Ga 68 dotatate 2etoposide phosphate 2Vincristine 2Thiotepa 2Temozolomide 2Mesna 2Magnetic Resonance Spectroscopy 2Etoposide 2Cyclophosphamide 2Carboplatin 23-Iodobenzylguanidine 2naxitamab 1fludarabine 1eliglustat 1Vaccines, DNA 1Topotecan 1Tamoxifen 1Rituximab 1Lenalidomide 1Isotretinoin 1Irinotecan 1Ifosfamide 1Hydrocortisone 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Ga(III)-DOTATOC 1Filgrastim 1Doxorubicin 1Cisplatin 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Neuroblastoma × 3-fluorobenzylguanidine × Clear all
NCT05069220 2024-03-01

18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Recruiting
150 enrolled
CNSEndocrineNET

Neuroblastoma, Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡